U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07726966) titled 'Betacyanin for Early Diagnosis and Recovery of Anastomotic Leakage After Rectal Cancer Surgery: A Single-Center, Prospective, Controlled Trial' on July 21.

Brief Summary: This single-center, prospective, controlled trial compares betacyanin versus conventional methods for early diagnosis and healing assessment of anastomotic leakage after rectal cancer surgery.

Study Start Date: Aug. 20

Study Type: INTERVENTIONAL

Condition: Rectum Cancer Anastomotic Leak

Intervention: DIETARY_SUPPLEMENT: Betacyanin

200 mL oral betacyanin solution administered daily from postoperative day 3 until discharge or confirmation of anastomotic leakag...